🔓
Sign in as a Member to unlock the full view of S.3064. · Full carveout list, all affected companies, party defectors, and 30-day trade predictions.
Become a Member$24.50/mo already a Member? Sign in →
S.3064 · 119TH CONGRESS

Relief of Chronic Pain Act of 2025

Status
In Committee
Latest Action
2025-10-28
Sponsor
Daines, Steve (R-Montana)
Official Source
Investability
0/100
Stage
COMMITTEE
Related Bills
0
Full Text
Unavailable
Alive
Yes

What This Bill Does · Plain English

Summary · Congress.gov
Relief of Chronic Pain Act of 2025 This bill reduces cost-sharing and prohibits the imposition of certain utilization requirements under the Medicare prescription drug benefit for certain non-opioid drugs for chronic pain management. Specifically, the bill requires such drugs to be covered without a deductible and to be placed on the lowest cost-sharing tier (if any). The bill also prohibits the imposition of prior authorization requirements (i.e., requiring prior approval from a plan) or step therapy requirements (i.e., requiring the use of alternative drugs before a drug is covered under a plan) with respect to such drugs.

Frequently Asked Questions

Did S.3064 pass?
S.3064 is still alive. Current stage: COMMITTEE. Pass likelihood: pending.
What does S.3064 do?
Relief of Chronic Pain Act of 2025 This bill reduces cost-sharing and prohibits the imposition of certain utilization requirements under the Medicare prescription drug benefit for certain non-opioid drugs for chronic pain management. Specifically, the bill requires such drugs to be covered without a deductible and to be placed on the lowest cost-sharing tier (if any). The bill also prohibits the imposition of prior authorization requirements (i.e., requiring prior approval from a plan) or step therapy requirements (i.e., requiring the use of alternative drugs before a drug is covered under a p…
Who sponsored S.3064?
S.3064 was sponsored by Steve Daines (R-Montana).

Full Bill Text

Full text not yet indexed for this bill. Check Congress.gov for the official text.
🔒 GovGreed Pro · Trading Intelligence on S.3064 Get Access — $24.50/mo
Loading intelligence layer…
Bill text sourced from GovInfo.gov · public domain · last updated 2026-09-14. Plain-English summary, score breakdown, and trading-intelligence panels are GovGreed-original analysis derived from STOCK Act filings, SEC Form 4 disclosures, FEC contributions, and Senate LDA lobbying reports — all publicly filed federal records. GovGreed is not affiliated with the U.S. Government. Not financial advice. [live render]